EP0792282A4 - Human endothelin-bombesin receptor - Google Patents

Human endothelin-bombesin receptor

Info

Publication number
EP0792282A4
EP0792282A4 EP94931401A EP94931401A EP0792282A4 EP 0792282 A4 EP0792282 A4 EP 0792282A4 EP 94931401 A EP94931401 A EP 94931401A EP 94931401 A EP94931401 A EP 94931401A EP 0792282 A4 EP0792282 A4 EP 0792282A4
Authority
EP
European Patent Office
Prior art keywords
bombesin receptor
human endothelin
endothelin
human
bombesin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP94931401A
Other languages
German (de)
French (fr)
Other versions
EP0792282A1 (en
Inventor
Yi Li
Chandrika Kumar
Craig A Rosen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
SmithKline Beecham Corp
Original Assignee
Human Genome Sciences Inc
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc, SmithKline Beecham Corp filed Critical Human Genome Sciences Inc
Publication of EP0792282A1 publication Critical patent/EP0792282A1/en
Publication of EP0792282A4 publication Critical patent/EP0792282A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus
EP94931401A 1994-10-17 1994-10-17 Human endothelin-bombesin receptor Withdrawn EP0792282A4 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1994/011843 WO1996011946A1 (en) 1994-10-17 1994-10-17 Human endothelin-bombesin receptor

Publications (2)

Publication Number Publication Date
EP0792282A1 EP0792282A1 (en) 1997-09-03
EP0792282A4 true EP0792282A4 (en) 1999-03-24

Family

ID=22243139

Family Applications (1)

Application Number Title Priority Date Filing Date
EP94931401A Withdrawn EP0792282A4 (en) 1994-10-17 1994-10-17 Human endothelin-bombesin receptor

Country Status (4)

Country Link
EP (1) EP0792282A4 (en)
JP (1) JPH11501205A (en)
AU (1) AU8019494A (en)
WO (1) WO1996011946A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2239293A1 (en) 1995-12-11 1997-06-19 New England Medical Center Hosptials, Inc. Assay for and uses of peptide hormone receptor ligands
US5750353A (en) * 1995-12-11 1998-05-12 New England Medical Center Hospitals, Inc. Assay for non-peptide agonists to peptide hormone receptors
US6143521A (en) * 1998-07-22 2000-11-07 Smithkline Beecham Corporation Human bombesin receptor subtype-3sb
GB9925115D0 (en) * 1999-10-22 1999-12-22 Pfizer Ltd Novel polypeptide
GB0006289D0 (en) * 2000-03-15 2000-05-03 Smithkline Beecham Plc New use
JP2003018992A (en) * 2001-06-28 2003-01-21 Inst Of Physical & Chemical Res Pael receptor, pael receptor expression cell and animal, amd method for screening drug for parkinson disease

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
No further relevant documents disclosed *
See also references of WO9611946A1 *

Also Published As

Publication number Publication date
EP0792282A1 (en) 1997-09-03
WO1996011946A1 (en) 1996-04-25
AU8019494A (en) 1996-05-06
JPH11501205A (en) 1999-02-02

Similar Documents

Publication Publication Date Title
PL328822A1 (en) Human bikinine
EP0828751A4 (en) Human neuropeptide receptor
GB2297902B (en) Reclining device
ZA9510686B (en) Human somatostatin-like receptor
GB9517098D0 (en) Receptor
GB9607441D0 (en) Human hyaluronan receptor
EP0815133A4 (en) Human stat4
GB9620777D0 (en) Therapeutic use
HUP9901448A3 (en) Novel medical use
AU6035398A (en) Human c5a-like receptor
EP0792282A4 (en) Human endothelin-bombesin receptor
GB9509016D0 (en) Tissue entrapment
EP0797592A4 (en) Human stanniocalcin-alpha
EP0832124A4 (en) Human amine receptor
ZA947865B (en) Human glactokinase
GB9425502D0 (en) Novel receptor
ZA948394B (en) Human endothelin-bombesin receptor
EP0795006A4 (en) HUMAN MutT2
GB9722388D0 (en) NIP45 human homolog
ZA977005B (en) Therapeutic uses
GB9617550D0 (en) Medical ice-pack
HUT72850A (en) Human interleukin-6-inhibitor
ZA949714B (en) Human MutT2
GB9403561D0 (en) Novel receptor
ZA953792B (en) Human neuropeptide receptor

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19970515

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

RHK1 Main classification (correction)

Ipc: C12N 15/12

A4 Supplementary search report drawn up and despatched

Effective date: 19990205

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20020115

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20050819